Varian Medical Systems (VAR) Receives Analyst Rating

Varian Medical Systems (VAR) : Zacks Investment Research ranks Varian Medical Systems (VAR) as 3, which is a Hold recommendation. 3 research analysts consider that the stocks fundamentals point to a bright future, hence they rate the stock as a Strong Buy. 1 more believe that the stock has more downside risks, hence they propose a Strong Sell. A total of 1 analysts believe that the stock has a limited upside, hence they advise a Hold. The average broker rating of 5 research analysts is 2.06, which indicates as a Buy.

Varian Medical Systems (VAR) : 5 Wall Street analysts covering Varian Medical Systems (VAR) believe that the average level the stock could reach for the short term is $93.4. The maximum price target given is $102 and the minimum target for short term is around $86, hence the standard deviation is calculated at $6.47.


Also, Citigroup maintains their rating on the shares of Varian Medical Systems (NYSE:VAR). The current rating of the shares is Neutral. Equity Analysts at the Firm raises the price target to $88 per share from $84 per share. The rating by the firm was issued on July 28, 2016.

Varian Medical Systems (NYSE:VAR): After opening at $94.6, the stock dipped to an intraday low of $94.45 on Thursday. However, the bulls stepped in to buy at lower levels and pushed the stock higher. The stock touched an intraday high of $96.39 and the buying power remained strong till the end. The stock closed at $96.15 for the day, a gain of 1.66% for the day session. The total traded volume was 515,462. The stocks close on the previous trading day was $94.58.

Varian Medical Systems Inc. is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy. The Company is a supplier of X-ray imaging components for medical, scientific, and industrial applications and supplies X-ray imaging products for cargo screening and industrial inspection. The Company offers tools for fighting cancer, taking X-ray images and protecting ports and borders. The Companys products include linear accelerators, brachytherapy afterloaders, treatment simulation and verification equipment, accessories, information management, treatment planning and image processing software. The Companys customers include university research and community hospitals, private and governmental institutions, healthcare agencies, doctors offices and cancer care clinics.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.